Literature DB >> 26905760

Precursor-directed biosynthesis of new sansanmycin analogs bearing para-substituted-phenylalanines with high yields.

Ningning Zhang1, Li Liu1, Guangzhi Shan1, Qiang Cai1, Xuan Lei1, Bin Hong1, Linzhuan Wu1, Yunying Xie1, Ruxian Chen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26905760     DOI： 10.1038/ja.2016.2

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  10 in total

1.  Two novel nucleosidyl-peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS.

Authors:  Yunying Xie; Hongzhang Xu; Chenghang Sun; Ying Yu; Ruxian Chen
Journal:  J Antibiot (Tokyo)       Date:  2010-02-05       Impact factor: 2.649

2.  Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa.

Authors:  Naomasa Gotoh; Takeshi Murata; Toru Ozaki; Tadashi Kimura; Akiko Kondo; Takeshi Nishino
Journal:  J Infect Chemother       Date:  2003-03       Impact factor: 2.211

Review 3.  Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis.

Authors:  Michael Winn; Rebecca J M Goss; Ken-ichi Kimura; Timothy D H Bugg
Journal:  Nat Prod Rep       Date:  2009-12-16       Impact factor: 13.423

4.  Identification of the biosynthetic gene cluster for the pacidamycin group of peptidyl nucleoside antibiotics.

Authors:  Wenjun Zhang; Bohdan Ostash; Christopher T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-08       Impact factor: 11.205

5.  NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues.

Authors:  Yunying Xie; Qiang Cai; Hao Ren; Lifei Wang; Hongzhang Xu; Bin Hong; Linzhuan Wu; Ruxian Chen
Journal:  J Nat Prod       Date:  2014-06-25       Impact factor: 4.050

6.  Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82,11372.

Authors:  S Chatterjee; S R Nadkarni; E K Vijayakumar; M V Patel; B N Ganguli; H W Fehlhaber; L Vertesy
Journal:  J Antibiot (Tokyo)       Date:  1994-05       Impact factor: 2.649

7.  Sansanmycins B and C, new components of sansanmycins.

Authors:  Yunying Xie; Hongzhang Xu; Shuyi Si; Chenghang Sun; Ruxian Chen
Journal:  J Antibiot (Tokyo)       Date:  2008-04       Impact factor: 2.649

8.  Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. II. Structural elucidation.

Authors:  F Isono; M Inukai; S Takahashi; T Haneishi; T Kinoshita; H Kuwano
Journal:  J Antibiot (Tokyo)       Date:  1989-05       Impact factor: 2.649

9.  Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation.

Authors:  R H Chen; A M Buko; D N Whittern; J B McAlpine
Journal:  J Antibiot (Tokyo)       Date:  1989-04       Impact factor: 2.649

10.  A new nucleosidyl-peptide antibiotic, sansanmycin.

Authors:  Yunying Xie; Ruxian Chen; Shuyi Si; Chenghang Sun; Hongzhang Xu
Journal:  J Antibiot (Tokyo)       Date:  2007-02       Impact factor: 2.649
  10 in total
  1 in total

1.  Improving the N-terminal diversity of sansanmycin through mutasynthesis.

Authors:  Yuanyuan Shi; Zhibo Jiang; Xuan Lei; Ningning Zhang; Qiang Cai; Qinglian Li; Lifei Wang; Shuyi Si; Yunying Xie; Bin Hong
Journal:  Microb Cell Fact       Date:  2016-05-06       Impact factor: 5.328
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.